Molecular Imaging For Whole Body Visualisation Of Diseases

In collaboration with the Finnish company, Pharmatest, we are developing preclinical efficacy models for osteoarthritis (OA) that would be relevant for the pathophysiology of adult human articular cartilage and human OA. Our work addresses an unmet need which would characterize the progressive destruction of articular cartilage and allow for novel tools and new therapies to be developed which can stimulate the repair of articular cartilage. We are currently focusing on mechanisms that impact upon MAP kinase functions.